BrainsWay Announces Innovative Deep Transcranial Magnetic Stimulation System Showcase Presentation at this Year’s Psych Congress Meeting

NEXT STORY
11th Annual American Kidney Fund Gala, The Hope Affair, Honors People Fighting Kidney Disease
PREV STORY
PDS Biotechnology Prioritizes Development of PDS0101 in Advanced Cancers Following Promising Phase 1 Clinical Outcome Data
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Conférence mondiale sur le cancer du poumon (« World Conference on Lung Cancer ») – conférence de presse du mercredi : Application des découvertes et thèmes de la conférence au monde réel

TORONTO, 28 sept. 2018 (GLOBE NEWSWIRE) -- Le point de presse final de la ...

author_avatar
NASDAQ Market News

Actinium Strengthens Executive Team and Enhances Clinical Development Capabilities with the Appointment of Dr. Mark Berger as Chief Medical Officer

Dr. Berger brings 20 years of drug development experience highlighted by the FDA approvals ...

author_avatar
NASDAQ Market News

Affimed Reports Financial Results for Second Quarter 2018 and Operational Progress

Heidelberg, Germany, August 8, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical ...

author_avatar
NASDAQ Market News